|
Index of reports
> All cases (744)
> Cases with Breast Cancer Metastatic (236)
Below is the selection of adverse event reports related to Premarin (Conjugated Estrogens) that includes all cases where reactions include breast cancer metastatic.
Reports 1 - 25 of 236 Next >>
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Climara
Premarin
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Estrogen NOS
Premarin
Prempro
Dosage: unspecified
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1984-01-01
End date: 1997-04-01
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Premarin
Prempro
Dosage: unspecified
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1982-01-01
End date: 2001-01-01
Prempro
Indication: Menopausal Symptoms
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female, weighing 57.7 kg (126.9 pounds)
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Cycrin
Premarin
Prempro
Dosage: not specified
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1990-01-01
End date: 2001-01-01
Prempro
Indication: Menopausal Symptoms
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Cycrin
Dosage: unknown
Indication: Hormone Replacement Therapy
Medroxyprogesterone Acetate
Dosage: unknown
Indication: Hormone Replacement Therapy
Premarin
Premarin
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Prempro
Dosage: unknown
Indication: Hormone Replacement Therapy
Provera
Dosage: unknown
Indication: Hormone Replacement Therapy
Unspecified Estrogen Replacement Therapy
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Premarin
Prempro / Premphase
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: hospitalization
Suspect drug(s):
Estrace
Estradiol
Medroxyprogesterone Acetate
Premarin
Prempro
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Premarin
Indication: Oestrogen Replacement Therapy
Prempro
Dosage: unknown
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1996-01-01
End date: 1998-01-01
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: hospitalization
Suspect drug(s):
Medroxyprogesterone Acetate
Indication: Hormone Replacement Therapy
Premarin
Indication: Hormone Replacement Therapy
Provera
Indication: Hormone Replacement Therapy
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Premarin
Prempro / Premphase
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Cycrin
Indication: Hormone Replacement Therapy
Premarin
Indication: Hormone Replacement Therapy
Prempro
Indication: Hormone Replacement Therapy
Provera
Indication: Hormone Replacement Therapy
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: hospitalization
Suspect drug(s):
Estrace
Premarin
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Start date: 1994-01-01
End date: 1996-01-01
Prempro
Dosage: unknown
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1996-01-01
End date: 2002-01-01
Provera
Dosage: unknown
Indication: Hormone Replacement Therapy
Start date: 1996-01-01
End date: 2002-01-01
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Premarin (Conjugated Estrogens)
Other drugs received by patient: Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a physician from United States on 2007-10-29
Patient: female, weighing 58.6 kg (128.9 pounds)
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: hospitalization
Suspect drug(s):
Premarin (Conjugated Estrogens)
Other drugs received by patient: Remicade; Synthroid
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Cycrin
Dosage: unknown
Indication: Hormone Replacement Therapy
Premarin
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Premphase 14 / 14
Dosage: unknown
Indication: Hormone Replacement Therapy
Prempro
Dosage: unknown
Indication: Hormone Replacement Therapy
Unspecified Estrogen Replacement Therapy
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-10-29
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: death
Suspect drug(s):
Medroxyprogesterone Acetate
Dosage: unknown
Indication: Hormone Replacement Therapy
Start date: 2001-04-09
End date: 2002-07-26
Premarin
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Start date: 2001-04-25
End date: 2002-08-07
Premphase 14 / 14
Dosage: unknown
Indication: Hormone Replacement Therapy
Start date: 2001-02-01
End date: 2001-04-09
Prometrium
Dosage: unknown
Indication: Hormone Replacement Therapy
Start date: 2000-12-01
End date: 2000-12-15
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Conjugated Estrogens
Cycrin
Dosage: unknown
Indication: Hormone Replacement Therapy
Estrace
Estratest
Dosage: unknown
Indication: Hormone Replacement Therapy
Medroxyprogesterone Acetate
Dosage: unknown
Indication: Hormone Replacement Therapy
Premarin
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Premphase 14 / 14
Dosage: unknown
Indication: Hormone Replacement Therapy
Prempro
Dosage: unknown
Indication: Hormone Replacement Therapy
Provera
Dosage: unknown
Indication: Hormone Replacement Therapy
Unspecified Estrogen Replacement Therapy
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: hospitalization
Suspect drug(s):
Estratest
Medroxyprogesterone
Premarin
Prempro
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic, Depression
Suspect drug(s):
Premarin (Conjugated Estrogens)
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Premarin
Indication: Hormone Replacement Therapy
Prempro
Indication: Hormone Replacement Therapy
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-26
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: hospitalization
Suspect drug(s):
Premarin
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-10-26
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Premarin
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-10-24
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: hospitalization
Suspect drug(s):
Premarin
Premphase 14 / 14
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-24
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic, Myocardial Infarction
Suspect drug(s):
Premarin
Dosage: unspecified daily
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1993-02-08
End date: 1996-01-01
Prempro
Dosage: unspecified daily
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1996-12-04
End date: 2002-05-09
Provera
Dosage: unspecified daily
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1993-02-08
End date: 1996-01-01
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-24
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Premarin
Prempro
Provera
Page 1 Next >>
|
